VolitionRx Ltd

Stock Information

Symbol

NYSE MKT: VNRX

Price

Loading...

Change

Loading...

Shares Oustanding

23521219

MKT Cap

Loading...

Volume

Loading...

Company Overview

VolitionRx is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer. The tests are based on the science of Nucleosomics which is the practice of identifying and measuring nucleosomes in the bloodstream – an indication that cancer is present.

VolitionRx's goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. VolitionRx's research and development activities are currently centred in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the US and ultimately, worldwide.

IR Contact Information

Investor Relations
VolitionRx
Scott Powell
T: (646) 650-1351
investorrelations@volitionrx.com

Edison Advisors
Tirth Patel
T: (646) 653-7035
tpatel@edisongroup.com

Edison Advisors
Katherine Fennell
T: +44 (0) 20 7841 1556
kfennell@edisongroup.com

Transfer Agent
VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.vstocktransfer.com

We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. If you continue to browse the site, you will accept our use of cookies.